Literature DB >> 23224321

Inhibitory effect of tumor necrosis factor α on gluconeogenesis in perfused rat liver.

Aline Franco da Rocha1, Thaís Fernanda Liboni, Carolina Campos Lima Moreira, Daniele Romani Miksza, Camila Oliveira de Souza, Flaviane de Fatima Silva, Glaucia Regina Borba-Murad, Roberto Barbosa Bazotte, Helenir Medri de Souza.   

Abstract

Tumor necrosis factor α (TNFα) is a cytokine involved in many metabolic responses in both normal and pathological states. Considering that the effects of TNFα on hepatic gluconeogenesis are inconclusive, we investigated the influence of this cytokine in gluconeogenesis from various glucose precursors. TNFα (10 μg/kg) was intravenously injected in rats; 6 h later, gluconeogenesis from alanine, lactate, glutamine, glycerol, and several related metabolic parameters were evaluated in situ perfused liver. TNFα reduced the hepatic glucose production (p < 0.001), increased the pyruvate production (p < 0.01), and had no effect on the lactate and urea production from alanine. TNFα also reduced the glucose production (p < 0.01), but had no effect on the pyruvate production from lactate. In addition, TNFα did not alter the hepatic glucose production from glutamine nor from glycerol. It can be concluded that the TNFα inhibited hepatic gluconeogenesis from alanine and lactate, which enter in gluconeogenic pathway before the pyruvate carboxylase step, but not from glutamine and glycerol, which enter in this pathway after the pyruvate carboxylase step, suggesting an important role of this metabolic step in the changes mediated by TNFα.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224321     DOI: 10.1007/s11010-012-1531-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

1.  Tumor necrosis factor-alpha alters glucose metabolism in suckling rats.

Authors:  T Battelino; M Goto; C Krzisnik; W P Zeller
Journal:  J Lab Clin Med       Date:  1999-06

2.  TNFalpha decreases gluconeogenesis in hepatocytes isolated from 10-day-old rats.

Authors:  M Goto; T Yoshioka; T Battelino; T Ravindranath; W P Zeller
Journal:  Pediatr Res       Date:  2001-04       Impact factor: 3.756

3.  Inflammation inhibits the expression of phosphoenolpyruvate carboxykinase in liver and adipose tissue.

Authors:  Kenneth R Feingold; Arthur Moser; Judy K Shigenaga; Carl Grunfeld
Journal:  Innate Immun       Date:  2011-03-30       Impact factor: 2.680

4.  Decreased response to cAMP in the glucose and glycogen catabolism in perfused livers of Walker-256 tumor-bearing rats.

Authors:  Hely de Morais; Priscila Cassola; Carolina Campos Lima Moreira; Suéllen Kathiane Fernandes Vilas Bôas; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Mol Cell Biochem       Date:  2012-05-26       Impact factor: 3.396

5.  Gluconeogenesis in tumor-influenced hepatocytes.

Authors:  M S Roh; L Ekman; M Jeevanandam; M F Brennan
Journal:  Surgery       Date:  1984-08       Impact factor: 3.982

6.  Gluconeogenesis from alanine in patients with progressive malignant disease.

Authors:  C Waterhouse; N Jeanpretre; J Keilson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

7.  Effect of tumor necrosis factor on enzymes of gluconeogenesis in the rat.

Authors:  W G Yasmineh; A Theologides
Journal:  Proc Soc Exp Biol Med       Date:  1992-01

8.  Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer.

Authors:  J Nakashima; M Tachibana; M Ueno; A Miyajima; S Baba; M Murai
Journal:  Clin Cancer Res       Date:  1998-07       Impact factor: 12.531

9.  Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.

Authors:  Rolf Grempler; Anne Kienitz; Torsten Werner; Marion Meyer; Andreas Barthel; Fabienne Ailett; Calum Sutherland; Reinhard Walther; Dieter Schmoll
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

10.  TNF-alpha is involved in activating DNA fragmentation in skeletal muscle.

Authors:  N Carbó; S Busquets; M van Royen; B Alvarez; F J López-Soriano; J M Argilés
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

View more
  2 in total

1.  Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.

Authors:  Yash Chhabra; Caroline N Nelson; Monika Plescher; Johanna L Barclay; Aaron G Smith; Sof Andrikopoulos; Salvatore Mangiafico; David J Waxman; Andrew J Brooks; Michael J Waters
Journal:  FASEB J       Date:  2019-02-19       Impact factor: 5.191

2.  Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats.

Authors:  Silvania da Silva Teixeira; Ana C Panveloski-Costa; Aline Carvalho; Fabiana P Monteiro Schiavon; Any de Castro Ruiz Marque; Raquel S Campello; Roberto B Bazotte; Maria T Nunes
Journal:  Physiol Rep       Date:  2016-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.